Cited by 24Artificial Intelligence in Healthcare and EducationInternet of Things and AIMobile Health and mHealth Applications

Integrating Artificial Intelligence-Driven Wearable Technology in Oncology Decision-Making: A Narrative Review

Open access
Birla, Meghna, Rajan, Roy, Prabhat Gautam, Gupta, Ishaan, Malik, Prabhat Singh·2024·Oncology

Abstract

Background: Clinical decision-making in oncology is a complex process influenced by numerous disease-related factors, patient demographics, and logistical considerations. With the advent of artificial intelligence (AI), precision medicine is undergoing a shift toward more precise and personalized care. Wearable device technology complements this paradigm shift by offering continuous monitoring of patient vitals, facilitating early intervention, and improving treatment adherence. The integration of these technologies promises to enhance the quality of oncological care, making it more responsive and tailored to individual patient needs, thereby enabling wider implementation of such applications in the clinical setting. Summary: This review article addresses the integration of wearable devices and AI in oncology, exploring their role in patient monitoring, treatment optimization, and research advancement along with an overview of completed clinical trials and utility in different aspects. The vast applications have been exemplified using several studies, and all the clinical trials completed till date have been summarized in Table 2. Additionally, we discuss challenges in implementation, regulatory considerations, and future perspectives for leveraging these technologies to enhance cancer care and radically changing the global health sector. Key Messages: AI is transforming cancer care by enhancing diagnostic, prognostic, and treatment planning tools, thus making precision medicine more effective. Wearable technology facilitates continuous, noninvasive monitoring, improving patient engagement and adherence to treatment protocols. The combined use of AI and wearables aids in monitoring patient activity, assessing frailty, predicting chemotherapy tolerance, detecting biomarkers, and managing treatment adherence. Despite these advancements, challenges such as data security, privacy, and the need for standardized devices persist. In the foreseeable future, wearable technology can hold significant potential to revolutionize personalized oncology care, empowering clinicians to deliver comprehensive and tailored treatments alongside standard therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000540494

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [37]Torrente M, Sousa PA, Hernández R, Blanco M, Calvo V, Collazo A,. An artificial intelligence-based tool for data analysis and prognosis in cancer patients: results from the clarify study. Cancers. 2022; 14(16): 4041. 36011034 PMC9406336
  2. [39]e Silva BVR, Rad MG, Cui J, McCabe M, Pan K. A mobile-based diet monitoring system for obesity management. J Health Med Inform. 2018; 9(2): 307. 30416865 PMC6226023
  3. [40]Weeks WA, Dua A, Hutchison J, Joshi R, Li R, Szejer J,. A low-power, low-cost ingestible and wearable sensing platform to measure medication adherence and physiological signals. 2018 40th annual international conference of the IEEE engineering in medicine and biology society (EMBC) IEEE; 2018. p. 5549– 53. 30441594
  4. [41]Nemati E, Liaqat D, Rahman MM, Kuang J. A novel algorithm for activity state recognition using smartwatch data. 2017 IEEE healthcare innovations and point of care technologies (HI-POCT) IEEE; 2017. p. 18– 21.
  5. [42]Mortazavi B, Nemati E, VanderWall K, Flores-Rodriguez HG, Cai JYJ, Lucier J,. Can smartwatches replace smartphones for posture tracking? Sensors. 2015; 15(10): 26783– 800. 26506354 PMC4634473
  6. [46]Liu J-H, Shih C-Y, Huang H-L, Peng J-K, Cheng S-Y, Tsai J-S,. Evaluating the potential of machine learning and wearable devices in end-of-life care in predicting 7-day death events among patients with terminal cancer: cohort study. J Med Internet Res. 2023; 25: e47366. 37594793 PMC10474512

Cited by

Sorted by citations

Authors
Birla, M., Rajan, Roy, P. G., Gupta, I., & Malik, P. S.
Affiliations
  • DR. B.R.A. Institute Rotary Cancer Hospital (IN)
  • Indian Institute of Technology Delhi (IN)
Corresponding author
Malik, Prabhat Singh
Venue
Oncology
Publisher
S. Karger AG
Published
2024-07-25
Volume
103
Issue
1
Pages
1-13
ISSN
  • 0030-2414 (ISSN-L)
  • 1423-0232
OpenAlex
W4401103313
Cited by
20
References
44
Citations by year
2026: 7 · 2025: 13
FWCI
0.46
Type
journal article
Language
en
Open access
Locations
  • Oncology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Information Systems › Internet of Things and AI
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
artificial intelligence, wearable devices, clinical decision-making, precision medicine, continuous patient monitoring, medication adherence, frailty assessment, biomarker detection, data security and privacy, regulatory considerations, precision oncology
MeSH terms
Clinical Decision-Making, Wearable Electronic Devices, Artificial Intelligence, Humans, Medical Oncology, Neoplasms, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review